Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J, Zhuang C, Liu Y, Chen M, Chen Y, Chen Z, He A, Lin J, Zhan Y, Liu L, Xu W, Zhao G, Guo Y, Wu H, Cai Z, Huang W.
Li J, et al. Among authors: liu y, liu l.
J Exp Clin Cancer Res. 2016 Jun 21;35(1):99. doi: 10.1186/s13046-016-0372-5.
J Exp Clin Cancer Res. 2016.
PMID: 27328915
Free PMC article.